| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/29/2001 | US6239332 Constructs and methods for enhancing protein levels in photosynthetic organisms |
| 05/29/2001 | US6239331 Enhancement of tomato phytoene synthase gene expression with a modified DNA |
| 05/29/2001 | US6239330 Fumonisin detoxification compositions and methods |
| 05/29/2001 | US6239329 Shoot meristem specific promoter sequences |
| 05/29/2001 | US6239328 Method for reducing expression variability of transgenes in plant cells |
| 05/29/2001 | US6239327 Nucleotide sequence of gene involvedn in cell proliferation in endosperm and embryo; has set domain and/or cxc domain; for parthenocarpy, apomixis, or seed specific characteristics |
| 05/29/2001 | US6239326 Sparc-deficient transgenic mice |
| 05/29/2001 | US6239272 Oligonucleotide having one or more modified nucleotides of defined structure; antisense agents; ribozymes |
| 05/29/2001 | US6239268 Nucleotide and amino acid sequences; recombinant culture production; antibodies; primers; probes; diagnosis and treatment of rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, myasthemia gravis, scleroderma |
| 05/29/2001 | US6239267 Nucleotide sequence of ion channel protein associated with capsaicin; diagnosis and treatment of nervous system disorders, incontinence, stroke; antiischemic agents; antiarthritic/antiinflammatory agents; analgesics |
| 05/29/2001 | US6239265 Oligonucleotides having chiral phosphorus linkages |
| 05/29/2001 | US6239264 Nucleotide sequences; cloning vectors; transformed host cells; primers for detection |
| 05/29/2001 | US6239260 Binding compositions specific for interleukin-10 |
| 05/29/2001 | US6239259 Multivalent and multispecific antigen-binding protein |
| 05/29/2001 | US6239256 Isolated muteins of proteins SCP-1, and compositions containing the mutein |
| 05/29/2001 | US6239159 Nucleoside analogues |
| 05/29/2001 | US6239116 Immunostimulatory nucleic acid molecules |
| 05/29/2001 | US6239106 Family of protease inhibitors, and other biologic active substances |
| 05/29/2001 | US6239101 Thrombin binding polypeptides |
| 05/29/2001 | US6239100 Isolated polypeptide capable of fish growth promoting activity and comprising specified amino acid sequence |
| 05/29/2001 | US6238924 In situ genetic recombination in yeast, bacteria or mammals; insert synthetic gene coding endonuclease into expression vector, transform cells of yeast, bacteria, or mammals and detect insertion into chromosome |
| 05/29/2001 | US6238923 Method for multifragment in vivo cloning and mutation mapping |
| 05/29/2001 | US6238921 Antisense oligonucleotide modulation of human mdm2 expression |
| 05/29/2001 | US6238918 DNA sequence encoding the tumor suppressor gene ING1 |
| 05/29/2001 | US6238917 Polynucleotides |
| 05/29/2001 | US6238916 Nucleotide sequences coding brain polypeptide; for use as tools in genetic engineering |
| 05/29/2001 | US6238915 Protein for the treament of preferential genetic disorders |
| 05/29/2001 | US6238914 Nucleic acid |
| 05/29/2001 | US6238910 Apparatus for automatic hybridization of nucleotide sequences; for accurate heating and fluid control during nucleotide sequence hybridization |
| 05/29/2001 | US6238905 Nucleotide sequence coding enzymatic protein; for use as tool in genetic engineering; for use in detection of amplification proteins |
| 05/29/2001 | US6238903 Purified, isolated nucleic acid |
| 05/29/2001 | US6238901 Nucleotide sequences coding a enzymatic polypeptide; for use as tools in genetic engineering |
| 05/29/2001 | US6238900 Nucleotide sequence coding enzymatic polypeptide; for the prevention of bacterial infections; bactericides |
| 05/29/2001 | US6238898 Hydroperoxide lyases |
| 05/29/2001 | US6238894 Culture product of helicobacter; catalyst |
| 05/29/2001 | US6238893 Method for intracellular DNA amplification |
| 05/29/2001 | US6238892 Preferential immunoglobulin for the diagnosis and treatment of alzheimer's disease and nervous system disorders |
| 05/29/2001 | US6238889 Amino acid sequence of interleukin-3; recombinant culture production |
| 05/29/2001 | US6238888 Keratinocyte growth factor-2 formulations |
| 05/29/2001 | US6238887 Ribosome recycling factor (FRR) of Staphylococcus aureus |
| 05/29/2001 | US6238883 Neurotransmitter transporter SC6 |
| 05/29/2001 | US6238882 Nucleotide sequence from streptococcus; diagnosis; drug screening for new bactericides; primers; probes; antibodies; vaccines |
| 05/29/2001 | US6238881 Nucleotide sequence which codes for p115 rho-guanine exchange factor involved in cell signalling; therapeutics; diagnostics; recombinant culture production; antibodies; probes |
| 05/29/2001 | US6238875 Immunoassay diagnosis of chronic lymphocytic leukemia in humans by detecting and quantitating gene expression of effector cell protease receptors on cd5 positive sample cells |
| 05/29/2001 | US6238873 Methods of screening for agonists and antagonists of the interaction between the human KIAA0001 receptor and ligands thereof |
| 05/29/2001 | US6238869 Contacting sample with nuclease protection fragments, exposing sample to nuclease to digest unprotected nucleic acid, contacting sample with probe array, and detecting target nucleic acid |
| 05/29/2001 | US6238867 Compositions, methods and kits for identifying naturally occurring RNA sequences having affinity for RNA-binding proteins |
| 05/29/2001 | US6238863 Materials and methods for indentifying and analyzing intermediate tandem repeat DNA markers |
| 05/29/2001 | US6238861 Neurofibromatosis gene |
| 05/29/2001 | US6238859 Virus protein antigens of the JC virus |
| 05/29/2001 | US6238858 Producing secondary virus such as togavirus or retrovirus in producer host cell for subsequent infection of target cells by using chimeric primary virus or combination which direct production in the host cells; gene therapy |
| 05/29/2001 | US6238669 Proteins encoded by chicken anemia virus DNA and diagnostic kits and vaccines employing said proteins |
| 05/29/2001 | US6238666 Polypeptide |
| 05/29/2001 | US6238624 A self-addressable, self-assembling microelectronic device is designed and fabricated to actively carry out and control multi-step and multiplex molecular biological reactions in microscopic formats. |
| 05/29/2001 | US6238565 Monolithic matrix for separating bio-organic molecules |
| 05/29/2001 | CA2325278A1 Nucleic acid-immobilized substrate |
| 05/29/2001 | CA2225450C Interleukin-1 receptor-associated protein kinase and assays |
| 05/29/2001 | CA2171638C The semaphorin gene family |
| 05/29/2001 | CA2171611C Analog of haemophilus hin47 with reduced protease activity |
| 05/29/2001 | CA2064915C Tumour necrosis factor binding ligands |
| 05/29/2001 | CA2034881C Factor x-laci hybrid protein |
| 05/29/2001 | CA2025938C Cloning of the gene which codes for the pilinic subunit fim3 of bordetella pertussis |
| 05/25/2001 | WO2001037291A1 Magnetic glass particles, method for their preparation and uses thereof |
| 05/25/2001 | WO2001037194A2 Crystallizable compositions comprising a caspase-7 |
| 05/25/2001 | WO2001036979A2 Placental human neurokinin b precursor |
| 05/25/2001 | WO2001036977A2 Identification of disease markers involving mass-based-separation |
| 05/25/2001 | WO2001036970A1 Method for assessing genotoxicity of a compound |
| 05/25/2001 | WO2001036958A1 Film based addressable programmable electronic matrix articles and methods of manufacturing and using the same |
| 05/25/2001 | WO2001036688A1 Method for detecting replication competent viruses in the sera of subjects receiving gene therapy |
| 05/25/2001 | WO2001036686A2 Genomic polymorphism for predicting therapeutic response |
| 05/25/2001 | WO2001036684A2 Mammalian toxicological response markers |
| 05/25/2001 | WO2001036683A2 Method for rapid and accurate identification of microorganisms |
| 05/25/2001 | WO2001036682A2 Long oligonucleotide arrays |
| 05/25/2001 | WO2001036681A2 Immunological detection of rna:dna hybrids on microarrays |
| 05/25/2001 | WO2001036677A1 Development of method for screening physiologically active pyrrole imidazole derivative |
| 05/25/2001 | WO2001036670A2 Diagnosis kit, method and microarray for determining human detoxification capacity |
| 05/25/2001 | WO2001036669A2 Method for the controlled implementation of complex pcr amplifications |
| 05/25/2001 | WO2001036668A1 Colour labelled oligonucleotide for labelling a nucleic acid molecule |
| 05/25/2001 | WO2001036659A2 Selectable cell surface marker genes |
| 05/25/2001 | WO2001036650A2 An oncolytic adenovirus |
| 05/25/2001 | WO2001036649A2 Isolation and characterization of the genomic dna clones of ribosomal protein gene l25 in tobacco |
| 05/25/2001 | WO2001036648A1 Recombinant oleosins from cacao and their use as flavoring or emulsifying agents |
| 05/25/2001 | WO2001036647A1 Transgenic plants exhibiting resistance to a broad spectrum of pathogens |
| 05/25/2001 | WO2001036646A1 Inhibiting gene expression with dsrna |
| 05/25/2001 | WO2001036645A2 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same |
| 05/25/2001 | WO2001036644A2 Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same |
| 05/25/2001 | WO2001036643A1 Nucleic acid construct for optimized production of products |
| 05/25/2001 | WO2001036642A1 HUMAN MONOCLONAL ANTIBODIES AGAINST TGF-βII RECEPTOR AND MEDICINAL USE THEREOF |
| 05/25/2001 | WO2001036641A2 DOUBLE-STRANDED RNA RECEPTOR (dsRNA-R) AND METHODS RELATING THERETO |
| 05/25/2001 | WO2001036640A2 Human fgf-21 gene and gene expression products |
| 05/25/2001 | WO2001036639A2 Bt toxin receptors from lepidopteran insects and methods of use |
| 05/25/2001 | WO2001036638A2 Polypeptides and nucleic acids encoding same |
| 05/25/2001 | WO2001036637A1 Receptor activator of nf-kappa b |
| 05/25/2001 | WO2001036636A2 Human notch ligand proteins and polynucleotides encoding the same |
| 05/25/2001 | WO2001036635A2 Neurite outgrowth-promoting factor homologue and nucleic acids encoding same |
| 05/25/2001 | WO2001036634A1 Novel g protein-coupled receptors, genes thereof and production and use of the same |
| 05/25/2001 | WO2001036633A1 Novel protein and dna thereof |
| 05/25/2001 | WO2001036632A2 Variants of alternative splicing |
| 05/25/2001 | WO2001036631A1 Human nogo-c polynucleotide and polypeptide and their uses |
| 05/25/2001 | WO2001036630A2 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |